Niagen Bioscience (NAGE) Current Assets (2016 - 2025)
Historic Current Assets for Niagen Bioscience (NAGE) over the last 15 years, with Q3 2025 value amounting to $93.6 million.
- Niagen Bioscience's Current Assets rose 7956.8% to $93.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $93.6 million, marking a year-over-year increase of 7956.8%. This contributed to the annual value of $64.1 million for FY2024, which is 2941.01% up from last year.
- Per Niagen Bioscience's latest filing, its Current Assets stood at $93.6 million for Q3 2025, which was up 7956.8% from $86.7 million recorded in Q2 2025.
- Niagen Bioscience's 5-year Current Assets high stood at $93.6 million for Q3 2025, and its period low was $37.9 million during Q3 2022.
- For the 5-year period, Niagen Bioscience's Current Assets averaged around $54.9 million, with its median value being $49.1 million (2024).
- Its Current Assets has fluctuated over the past 5 years, first tumbled by 3352.9% in 2022, then soared by 7956.8% in 2025.
- Over the past 5 years, Niagen Bioscience's Current Assets (Quarter) stood at $48.9 million in 2021, then fell by 4.78% to $46.6 million in 2022, then increased by 6.37% to $49.5 million in 2023, then rose by 29.41% to $64.1 million in 2024, then surged by 46.04% to $93.6 million in 2025.
- Its Current Assets stands at $93.6 million for Q3 2025, versus $86.7 million for Q2 2025 and $76.2 million for Q1 2025.